Edition:
United States

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

3.30USD
26 May 2017
Change (% chg)

$-0.05 (-1.49%)
Prev Close
$3.35
Open
$3.35
Day's High
$3.35
Day's Low
$3.20
Volume
2,258
Avg. Vol
18,094
52-wk High
$4.45
52-wk Low
$2.12

RICHARD KELLI

Institutional Holders

% Shares Owned: 77.43%
# of Holders: 53
Total Shares Held: 18,434,182
3 Mo. Net Change: 326,574
# New Positions: 5
# Closed Positions: 12
# Increased Positions: 16
# Reduced Positions: 27
# Net Buyers: -11

Officers & Directors

Name Age Since Current Position

John Clarke

63 2005 Independent Chairman of the Board

John Mendlein

57 2015 Chief Executive Officer, Director

John Blake

40 2017 Senior Vice President - Finance

David King

58 2016 Senior Vice President - Research

Grove Matsuoka

58 2016 Senior Vice President, Product Programs and Planning

Ashraf Amanullah

49 2015 Vice President, Biologics Development and Manufacturing

Sanuj Ravindran

45 2016 Chief Business Officer

Sanjay Shukla

45 2016 Chief Medical Officer

Timothy Coughlin

49 2017 Director

Jeffrey Hatfield

2017 Director

Srinivas Akkaraju

48 2015 Independent Director

James Blair

77 2010 Independent Director

Mark Goldberg

62 2015 Independent Director

Amir Nashat

44 2006 Independent Director

Paul Schimmel

76 2005 Independent Director